A Phase I Study Evaluating SCB-313 for the Treatment of Subjects With Peritoneal Carcinomatosis
Clinical trial NCT04047771 · TERMINATED
Trial details
- NCT number
- NCT04047771
- Sponsor
- Sichuan Clover Biopharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-10
- Primary completion
- 2022-05-05
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.